Chemo Lugano biosimilar division Mabxience granted Natco exclusive rights to four mAbs to treat cancer and autoimmune in India and parts of Asia

Chemo Lugano

Switzerland / Tools, Services, and Manufacturing

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Natco Pharma Ltd.

India / Small-Cap Biopharma (<$1 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced